- 201. Microtubule Bundle
- [It is the aggregated products of microtubules during mitosis where chromosomes line up prior to the segregation process. Many antineoplastic agents cause cytotoxicity by inducing microtubular bundle formation irreversibly. (NCI) ( NCI )] (UMLS (NCI) C1156020) =Molecular Function
| - 251. Midgut
- (UMLS (NCI) C0231052) =Embryonic Structure
|
- 202. Microtubule Depolymerization
- [Microtubule depolymerization is a cellular process typically, though not solely, involved in cell motility and cell division. Induction of microtubule depolymerization causes interruption of mitosis and is the mode of action of several antineoplastic agents. ( NCI )] (UMLS (NCI) C1156031) =Cell Function
| - 252. Midgut Carcinoid Neoplasm
- (UMLS (NCI) C1334763) Midgut Carcinoid Tumor;
=Neoplastic Process ;
|
- 203. Microtubule Polymerization
- [Microtubule polymerization is a cellular process typically, though not solely, involved in cell motility and cell division. Stabilization of microtubule polymerization causes interruption of mitosis and is the mode of action of several antineoplastic agents. ( NCI )] (UMLS (NCI) C1156032) =Cell Function
| - 253. MIDODRINE
- [A direct-acting prodrug and sympathomimetic agent with antihypotensive properties. Midodrine is converted to its active metabolite, desglymidodrine by deglycination reaction. Desglymidodrine selectively binds to and activates alpha-1-adrenergic receptors of the arteriolar and venous vasculature. This causes smooth muscle contraction and leads to an elevation of blood pressure. Desglymidodrine diffuses poorly across the blood-brain barrier, and is therefore not associated with effects on the central nervous system (CNS). ( NCI )] (UMLS (NCI) C0026078) =Organic Chemical; Pharmacologic Substance =Ethanolamines;
[CV900] CARDIOVASCULAR AGENTS, OTHER =(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide Monohydrochloride;
|
- 204. Microtubule Stabilization
- [Microtubule Stabilization consists of activities involved in maintenance of filamentous tubes of variable length in the cytoskeleton composed primarily of conserved alpha, beta, and gamma tubulin that support movement of chromosomes or chromatids during mitosis and meiosis; and give shape, structure, and organization to the cytoplasm and to a cell. ( NCI )] (UMLS (NCI) C1156027) =Cell Function
| - 254. Midostaurin
- [A synthetic, indolocarbazole protein kinase C (PKC) inhibitor with anti-angiogenic properties. Midostaurin selectively and reversibly binds to and inhibits PKC, thereby inhibiting PKC-mediated signal transduction pathways involved in the regulation of the cell cycle in tumor cells. This may result in cell cycle inhibition and tumor cell apoptosis. ( NCI )] (UMLS (NCI) C0526371) =Organic Chemical; Pharmacologic Substance ;
|
- 205. Microtubule-organizing Center
- [An amorphous region of electron dense material in the cytoplasm from which the MICROTUBULES polymerization is nucleated. The pericentriolar region of the CENTROSOME which surrounds the CENTRIOLES is an example. ( MSH )] (UMLS (NCI) C0242607) =Cell Component ;
| - 255. Midrin
- (UMLS (NCI) C0066532) =Organic Chemical; Pharmacologic Substance ;
|
- 206. Microunit per Milliliter
- (UMLS (NCI) C0439342) =Quantitative Concept
| - 256. MIDTARSAL FUSION
- [ ] (UMLS (ICD9CM) C0188827) =Therapeutic or Preventive Procedure
|
- 207. microvilli
- [Minute projections of cell membranes which greatly increase the surface area of the cell. ( MSH )] (UMLS (CSP) C0026049) =Cell Component ;
| - 257. midwife
- [A person (usually female) helping a woman deliver a baby. Responsibilities vary locally, ranging from a mere optional assistant to a full required participant, responsible for (normal) births and pre- and post-natal care for both mother and baby. ( HL7V3.0 )] (UMLS (HL7) C0026083) =Professional or Occupational Group ;
=ParticipationFunction;
|
- 208. microvillus dense body
- [ ] (UMLS (CSP) C0596945) =Cell Component ;
| - 258. Midwife, Certified
- [A provider educated in the independent management of women's health and focusing particularly on pregnancy, childbirth, the post-partum period, care of the newborn, family planning and gynecological needs of women and primary care of women. Certification requires education at the post-secondary level in midwifery and health services.Source: The American College of Nurse-Midwives, Position Statements, www.midwife.org/prof/defcnm.htm ( HL7V3.0 )] (UMLS (HL7) C1556030) =Intellectual Product =Other Service Providers;
|
- 209. Microviridae
- [A large family of lytic bacteriophages infecting enterobacteria; SPIROPLASMA; BDELLOVIBRIO; and CHLAMYDIA. It contains four genera: MICROVIRUS; Spiromicrovirus; Bdellomicrovirus; and Chlamydiamicrovirus. ( MSH )] (UMLS (CSP) C0206399) =Virus
| - 259. Midwife, Lay
- [A person qualified by experience and limited specialized training to provide obstetric and neo-natal care in the management of women having normal pregnancy, labor and childbirth. The lay midwife is licensed in some states. ( HL7V3.0 )] (UMLS (HL7) C1556031) =Intellectual Product =Other Service Providers;
|
- 210. microwave spectrometry
- [measuring the intensity of microwave radiation that is absorbed or emitted by a sample as a result of rotational transitions. ( CSP )] (UMLS (CSP) C0596946) =Laboratory Procedure ;
=spectrometry;
| - 260. midwifery
- [The practice of assisting women in childbirth. ( MSH )] (UMLS (CSP) C0026082) =Biomedical Occupation or Discipline ;
|
- 211. micturition
- [discharge or passage of urine. ( CSP )] (UMLS (CSP) C0042034) =Organism Function ;
=Elimination;
| - 261. MIF
- [protein factors released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of macrophages and leukocytes away from their site of release. ( CSP )] (UMLS (CSP) C0024429) =Amino Acid, Peptide, or Protein; Immunologic Factor =lymphokine;
|
- 212. MID FORCEPS OP NEC
- [ ] (UMLS (ICD9CM) C0177262) =Therapeutic or Preventive Procedure
| - 262. Mifegyne
- (UMLS (NCI) C0591786) =Steroid; Pharmacologic Substance
|
- 213. Mid forceps operation
- [ ] (UMLS (ICD9CM) C0542408) =Therapeutic or Preventive Procedure ;
| - 263. MIFENTIDINE
- (UMLS (NCI) C0128486) =Organic Chemical; Pharmacologic Substance ;
|
- 214. Mid forceps operation with episiotomy
- [ ] (UMLS (ICD9CM) C0177261) =Therapeutic or Preventive Procedure
| - 264. Mifeprex
- (UMLS (NCI) C0939382) =Steroid; Pharmacologic Substance
|
- 215. mid infrared spectrometry
- [ ] (UMLS (CSP) C0920589) =Laboratory Procedure
| - 265. Miglitol
- (UMLS (NCI) C0066535) =Organic Chemical; Pharmacologic Substance ;
=GLUCOSAMINE;
[HS502] HYPOGLYCEMIC AGENTS, ORAL =MIGLITOL 100 MG;
MIGLITOL 25 MG;
MIGLITOL 50 MG |
- 216. mid infrared spectroscopy
- [ ] (UMLS (CSP) C0920590) =Laboratory Procedure
| - 266. Migraine
- [neural condition characterized by a severe recurrent vascular headache, usually on one side of the head, often accompanied by nausea, vomiting, and photophobia, sometimes preceded by sensory disturbances; triggers include allergic reactions, excess carbohydrates or iodine in the diet, alcohol, bright lights or loud noises.(CSP)] (UMLS (ICPC) C0149931) (Migraine; MIGRAINA; Migraene; Migraine; MIGREENI; Migraine; Migraene; tzilxa; migraine; Emicrania; MIGRENE; Enxaqueca; Migrana; MIGRAN) =Disease or Syndrome =Central Nervous System Disease; Cefalea (ex N02 N89 R09); Vascular Headache; neurologic; Diagnosis/Diseases Component; =Common migraine; Classic Migraine;
|
- 217. MID-INNER EAR OPS NEC
- [ ] (UMLS (ICD9CM) C0161870) =Therapeutic or Preventive Procedure
| - 267. Migraine, unspecified, without mention of intractable migraine
- [ ] (UMLS (ICD9CM) C0375239) =Disease or Syndrome
|
- 218. Mid-level professional (nurse, nurse practitioner, physician's assistant)
- (UMLS (HL7) C1546963) =Idea or Concept =Primary Observer's Qualification;
| - 268. Migranal
- (UMLS (NCI) C0086157) =Organic Chemical; Pharmacologic Substance ;
|
- 219. MID/IN EAR DX PROC NEC
- [ ] (UMLS (ICD9CM) C0176340) =Diagnostic Procedure
| - 269. migrant
- [mobile, short-term residents who move usually to find work. ( CSP )] (UMLS (CSP) C0026093) =Population Group =named group;
|
- 220. Midaglizole
- (UMLS (NCI) C0128476) =Organic Chemical; Pharmacologic Substance ;
| - 270. Migrant Health
- (UMLS (HL7) C1552432) =Intellectual Product ;
=Clinic/Center;
|
- 221. Midamor
- (UMLS (NCI) C0026054) =Organic Chemical; Pharmacologic Substance
| - 271. Migrates to different CPU
- (UMLS (HL7) C1547199) =Idea or Concept =Application change type;
|
- 222. Middelburg virus
- [ ] (UMLS (CSP) C0318739) =Virus
| - 272. Migration
- [Pass from one part of the body or organ to another. ( NCI )] (UMLS (NCI) C0600210) =Activity
|
- 223. middle
- (UMLS (HL7) C1552826) =Idea or Concept =TableCellVerticalAlign;
| - 273. Mikamycin
- [A class of streptogramin-related depsipeptides isolated from the bacterium Streptomyces virginiae and other Streptomyces bacterial species. The virginiamycins consist of two major components, virginiamycin M1 and virginiamycin S1. These agents bind to and inhibit ribosome assembly, thereby preventing protein synthesis. Active against Gram-positive bacteria, these antibiotics are primarily used in veterinary practice. (NCI04) ( NCI )] (UMLS (NCI) C0042754) =Amino Acid, Peptide, or Protein; Antibiotic =cyclic peptide;
=N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(p-(Dimethylamino)benzyl)-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-(((3S)-3-quinuclidinylthio)methyl)-12H-pyrido(2,1-f)pyrrolo(2,1-l)(1,4,7,10,13,16)oxapentaazacyclononadecin-9-yl)-3-hydroxypicolinamide;
3R,4R,5E,10E,12E,14S,26R,26aS)-26-((2-(Diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone;
|
- 224. Middle
- [An intermediate part or section; an area that is approximately central within some larger region. ( NCI )] (UMLS (NCI) C0444598) =Spatial Concept
| - 274. mikamycin A
- [A streptomycin A-related cyclic depsipeptide isolated from the bacterium Streptomyces virginiae and other Streptomyces bacterial species. Virginiamycin M1 binds to and inhibits assembly of 50S and 30S ribosomes, thereby preventing protein synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0080320) =Amino Acid, Peptide, or Protein; Antibiotic
|
- 225. middle age
- [ ] (UMLS (CSP) C0026062) =Temporal Concept ;
| - 275. Mikulicz Disease
- [A chronic, benign, and usually painless inflammatory swelling of the lacrimal and salivary glands. It is considered by some to include the glandular enlargement associated with other diseases, such as Sjogren's syndrome, sarcoidosis, lupus erythematosus, etc. ( MSH )] (UMLS (NCI) C0026103) =Disease or Syndrome =Diseases of the salivary glands;
|
- 226. Middle Cardiac Vein
- (UMLS (NCI) C0226660) =Body Part, Organ, or Organ Component
| - 276. mil
- [1 x 10-3 [in_i] ( HL7V3.0 )] (UMLS (HL7) C1552926) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 227. Middle Cerebral Artery Branch
- (UMLS (NCI) C0923405) =Body Part, Organ, or Organ Component
| - 277. Mild
- (UMLS (HL7) C1547225) =Intellectual Product =Severity of Illness Code;
|
- 228. Middle Colic Artery
- (UMLS (NCI) C0226328) =Body Part, Organ, or Organ Component
| - 278. Mild
- (UMLS (HL7) C1563320) =Qualitative Concept ;
=Allergy Severity;
|
- 229. middle column
- [ ] (UMLS (CSP) C0599459) =Body Part, Organ, or Organ Component
| - 279. Mild Biliary Tract Dysplasia
- (UMLS (NCI) C0586359) =Disease or Syndrome
|
- 230. Middle Cranial Fossa
- [The compartment containing the anterior extremities and half the inferior surface of the temporal lobes (TEMPORAL LOBE) of the cerebral hemispheres. Lying posterior and inferior to the anterior cranial fossa (CRANIAL FOSSA, ANTERIOR), it is formed by part of the TEMPORAL BONE and SPHENOID BONE. It is separated from the posterior cranial fossa (CRANIAL FOSSA, POSTERIOR) by crests formed by the superior borders of the petrous parts of the temporal bones. ( MSH )] (UMLS (NCI) C0230045) =Body Space or Junction
| - 280. MILD COGNITIVE IMPAIREMT
- [ ] (UMLS (ICD9CM) C1719378) Mild cognitive impairment, so stated =Disease or Syndrome ;
|
- 231. Middle Ear Disorder
- [condition in which there is a deviation from or interruption of the normal structure or function of the middle ear, the tympanic cavity. ( CSP )] (UMLS (NCI) C0271428) =Disease or Syndrome =DISORDER OF EAR NOS;
=cholesteatoma;
otitis media | - 281. Mild Columnar Cell Atypia
- (UMLS (NCI) C0333877) =Cell or Molecular Dysfunction
|
- 232. MIDDLE EAR EXCISION NEC
- [ ] (UMLS (ICD9CM) C0176343) =Therapeutic or Preventive Procedure
| - 282. Mild Cytologic Atypia
- (UMLS (NCI) C0333866) =Cell or Molecular Dysfunction
|
- 233. Middle Ear Neoplasm
- (UMLS (NCI) C0345617) =Neoplastic Process
| - 283. Mild Dysplasia
- (UMLS (NCI) C0334046) =Cell or Molecular Dysfunction
|
- 234. Middle Ear Paraganglioma
- [A benign or malignant jugulotympanic paraganglioma arising from paraganglia in the middle ear. ( NCI )] (UMLS (NCI) C1334761) Non-Chromaffin Middle Ear Paraganglioma;
Non-Chromaffin Paraganglioma of Middle Ear;
Non-Chromaffin Paraganglioma of the Middle Ear;
Paraganglioma of Middle Ear;
Paraganglioma of the Middle Ear;
=Neoplastic Process | - 284. Mild Dysplasia of Rectum
- (UMLS (NCI) C0586371) =Disease or Syndrome
|
- 235. Middle Ear Polyp
- (UMLS (NCI) C0271466) =Neoplastic Process
| - 285. Mild Glandular Cell Atypia
- (UMLS (NCI) C0333881) =Cell or Molecular Dysfunction
|
- 236. MIDDLE EAR REPAIR NEC
- [ ] (UMLS (ICD9CM) C0176333) =Therapeutic or Preventive Procedure
| - 286. MILD HYPEREM GRAV-DELIV
- [ ] (UMLS (ICD9CM) C0156693) =Disease or Syndrome
|
- 237. Middle East
- [countries of southwest Asia and northeastern Africa usually considered as extending from Libya on the west to Afghanistan on the east. ( CSP )] (UMLS (NCI) C0026068) =Geographic Area ;
=Area;
=IL;
Arab country | - 287. MILD HYPEREM GRAV-UNSPEC
- [ ] (UMLS (ICD9CM) C0156692) =Disease or Syndrome
|
- 238. Middle Frontal Gyrus
- (UMLS (NCI) C0152297) =Body Part, Organ, or Organ Component
| - 288. Mild hyperemesis gravidarum
- (UMLS (ICD9CM) C0020451) =Disease or Syndrome
|
- 239. Middle Hemorrhoidal Artery
- (UMLS (NCI) C0226382) =Body Part, Organ, or Organ Component
| - 289. Mild hyperemesis gravidarum, antepartum
- [ ] (UMLS (ICD9CM) C0156694) =Disease or Syndrome
|
- 240. Middle Insomnia
- (UMLS (NCI) C0393761) =Mental or Behavioral Dysfunction
| - 290. mild intolerance
- [ ] (UMLS (CSP) C0872215) =Disease or Syndrome ;
|
- 241. Middle Lobe of the Prostate
- (UMLS (NCI) C0227972) =Body Part, Organ, or Organ Component
| - 291. Mild Koilocytotic Atypia
- (UMLS (NCI) C0333897) =Cell or Molecular Dysfunction
|
- 242. Middle Lobe of the Right Lung
- (UMLS (NCI) C0225757) =Body Part, Organ, or Organ Component
| - 292. MILD MENTAL RETARDATION
- (UMLS (ICD9CM) C0026106) =Mental or Behavioral Dysfunction
|
- 243. Middle Mediastinum
- (UMLS (NCI) C0230149) =Body Location or Region
| - 293. MILD NONPROLF DB RETNOPH
- [ ] (UMLS (ICD9CM) C1561894) Mild nonproliferative diabetic retinopathy;
=Disease or Syndrome |
- 244. Middle Phalanx of Finger
- (UMLS (NCI) C0223828) =Body Part, Organ, or Organ Component
| - 294. Mild or moderate birth asphyxia
- [ ] (UMLS (ICD9CM) C0456089) =Pathologic Function
|
- 245. Middle Temporal Gyrus
- (UMLS (NCI) C0152310) =Body Part, Organ, or Organ Component
| - 295. Mild or unspecified pre-eclampsia
- [ ] (UMLS (ICD9CM) C0269658) =Disease or Syndrome
|
- 246. Middle Temporal Sulcus
- (UMLS (NCI) C0228241) =Body Space or Junction
| - 296. Mild or unspecified pre-eclampsia, antepartum
- [ ] (UMLS (ICD9CM) C0156667) =Disease or Syndrome
|
- 247. Middle Third of the Esophagus
- (UMLS (NCI) C0227189) =Body Location or Region
| - 297. Mild or unspecified pre-eclampsia, postpartum
- [ ] (UMLS (ICD9CM) C0156668) =Disease or Syndrome
|
- 248. Middle Thyrohyoid Ligament
- (UMLS (NCI) C0225535) =Body Part, Organ, or Organ Component
| - 298. Mild or unspecified pre-eclampsia, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156664) =Disease or Syndrome
|
- 249. Middletown Rancheria of Pomo Indians of California
- (UMLS (HL7) C1554376) =Population Group =NativeEntityContiguous;
| - 299. Mild or unspecified pre-eclampsia, with delivery
- [ ] (UMLS (ICD9CM) C0156665) =Disease or Syndrome
|
- 250. midge
- [ ] (UMLS (CSP) C0026074) =Invertebrate ;
| - 300. Mild or unspecified pre-eclampsia, with delivery, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0156666) =Disease or Syndrome
|
home
